Can we safely target the WNT pathway?
Crossref DOI link:
Published Online: 2014-07-01
Published Print: 2014-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Text and Data Mining
valid from 2014-07-01
1 July 2014
The author is a consultant and equity holder in Prism Pharma Co. Ltd.